IRF3: Difference between revisions
CSV import |
No edit summary |
||
| Line 25: | Line 25: | ||
{{stub}} | {{stub}} | ||
== IRF3 == | == IRF3 == | ||
<gallery> | <gallery> | ||
File:Toll-like_receptor_pathways_revised.jpg|Toll-like receptor pathways revised | File:Toll-like_receptor_pathways_revised.jpg|Toll-like receptor pathways revised | ||
</gallery> | </gallery> | ||
Latest revision as of 00:02, 17 March 2025
IRF3 or Interferon Regulatory Factor 3 is a protein that in humans is encoded by the IRF3 gene. It is a member of the interferon regulatory transcription factor (IRF) family. IRF3 was originally discovered as a homolog of IRF1 and IRF2. It is found in an inactive cytoplasmic form that upon serine/threonine phosphorylation forms a complex with CREBBP. This complex translocates to the nucleus and activates the transcription of interferons alpha and beta, as well as other interferon-induced genes.
Function[edit]
IRF3 is a key transcription factor involved in the induction of interferon (IFN) in response to viral infection. It is activated by a variety of viruses, including herpes simplex virus, vesicular stomatitis virus, and Sendai virus. Upon activation, IRF3 translocates to the nucleus and binds to the IFN-stimulated response element (ISRE) in the promoter of IFN genes, leading to the production of IFN and the activation of IFN-stimulated genes.
Clinical significance[edit]
Mutations in the IRF3 gene have been associated with susceptibility to herpes simplex encephalitis, a rare complication of herpes simplex virus infection. Additionally, IRF3 has been implicated in the immune response to SARS-CoV-2, the virus that causes COVID-19. Studies have shown that SARS-CoV-2 can inhibit the activation of IRF3, thereby suppressing the production of IFN and evading the immune response.
See also[edit]
References[edit]
<references />
External links[edit]
- IRF3 at the National Center for Biotechnology Information


